0.590 (1.72%)

T-O: 0.0 (08:59:00)
Last updated: 17:00

Fundamental   3.2  
Technical   3.9  
Total Score   7.1  

 Insti+   Sector Trend+ 


iSaham Fundamental Trend

FCON: 0.66 | Sharpe Ratio: -0.12 | LTS: 6.31

Quarter Reports

Trailing Dividend

Financial Ratios

EPS 0.75 sen
Trailing PE (Sector Median: 42.4) 78.1
PEG 78.1
Altman Z 0.6
Beaver 0.063
Current Ratio 2.43
Debt-Equity (DE) Ratio 0.23
FCF Yield -1.19 %
Dividend Per Share (DPS) 0.17 sen
Revenue QoQ -3.25 %
Revenue YoY -2.25 %
Profit QoQ -2.12 %
Profit YoY -42.45 %
NTA QoQ -100.0 %
Profit Margin (Sector Median: 3.6) 8.64 %
ROE 1.68 %
ROIC 1.51 %
Dividend Yield (DY) 0.29 %

Fair Value

Weighted Average Fair Value: 0.32

Discounted Cash Flow (DCF) 5% Growth 0.07
Discounted Cash Flow (DCF) 10% Growth 0.095
Relative Valuation 0.32
Graham Formula 0.055
Graham Number 0.275
Net Tangible Asset (NTA) 0.0

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 304.08
Expected Revenue (M) 3519.47
Expected Growth (%) 48.0
Forward PE FV Calculator
Latest Profit 7.78
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value

Directors Share Purchases (Beta)

No transaction in the last 2 months.



Market Cap: 1024 M.

Number of Shares: 1736 M.

Float: 17.37%.

Stock highly correlated with


AFFIN (96%)

ANNJOO (96%)

ARREIT (96%)

Manipulation Indicator: Very hard to manipulate.

TMC Life Sciences Berhad, through its subsidiaries, provides a range of fertility treatment services in Malaysia. It is engaged in the development, marketing, management of healthcare programs; provision of storage of cord blood and adult stem cells, stem cell therapy, and application services. It operates women's clinic and medical center; and provides gynecological and fertility problem management, as well as consultancy, and research and development services. The company operates TMC fertility centers. The company was founded in 1994 and is headquartered in Petaling Jaya, Malaysia.

Sectors: Trading & Services, Healthcare, Medical Service & Equipment, Health Care Providers, Budget 2021, Joe Biden, Newly Classified Shariah-Compliant Securities

Code: 0101


Related Links: Bursa | Annual Report | Announcement

Top Shareholdings

Updated on 22-Nov-2019

Shareholder Value (M)
Sasteria (M) Pte. Ltd. 720.77
Dyam Tunku Ismail Ibni Sultan Ibrahim 78.47
Credit Suisse 50.49
Siow Wong Yen @ Siow Kwang Hwa 23.82
UOB Kay Hian Pte. Ltd. 21.66
CIMB Securities (Singapore) Pte. Ltd. 8.03
Anastasia Amanda Beh Gaik Sim 5.76
Lim Tien Lock Christopher 4.17
Lim Zhong Yong 3.08
UOB Kay Hian Pte Ltd 2.84
Lim Gaik Bway @ Lim Chiew Ah 2.72
Surinder Singh A/L Ranbir Singh 2.67
Ho Lin Meng 2.48
Wong Fuei Boon 2.4
Yip Tuck Leong 2.04
Joo & Lam Sendirian Berhad 1.74
Ng Aik Sern 1.7
Beh Eng Par 1.55
Wong Choon Keit 1.52
Lai Wei Chai 1.47
Chiew Poh Cheng 1.36
Lim Han Weng 1.18
Hooi Thien Eng 0.9
Mohd Salleh bin Hj Harun 0.84
DFA Emerging Markets Small Cap Series 0.81
Phillip Securities Pte. Ltd. 0.77